1. Home
  2. HUT vs FOLD Comparison

HUT vs FOLD Comparison

Compare HUT & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hut 8 Corp.

HUT

Hut 8 Corp.

HOLD

Current Price

$47.81

Market Cap

5.5B

Sector

Finance

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.44

Market Cap

4.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUT
FOLD
Founded
2011
2002
Country
United States
United States
Employees
N/A
511
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
4.5B
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
HUT
FOLD
Price
$47.81
$14.44
Analyst Decision
Strong Buy
Buy
Analyst Count
15
9
Target Price
$56.93
$27.25
AVG Volume (30 Days)
3.7M
2.8M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
$235,118,000.00
N/A
Revenue This Year
$161.69
$20.50
Revenue Next Year
N/A
$18.59
P/E Ratio
N/A
N/A
Revenue Growth
44.79
N/A
52 Week Low
$10.11
$5.66
52 Week High
$66.07
$14.46

Technical Indicators

Market Signals
Indicator
HUT
FOLD
Relative Strength Index (RSI) 46.82 68.84
Support Level $45.55 $14.21
Resistance Level $55.90 N/A
Average True Range (ATR) 3.61 0.02
MACD -0.26 -0.01
Stochastic Oscillator 40.85 77.78

Price Performance

Historical Comparison
HUT
FOLD

About HUT Hut 8 Corp.

Hut 8 Corp is an energy infrastructure platform that integrates power, digital infrastructure, and compute at scale to fuel next-generation, energy-intensive use cases. The company has four reportable business segments: Power, Digital Infrastructure, Compute, and Other. It derives maximum revenue from the Compute segment which consists of Bitcoin Mining, GPU-as-a-Service, and Data Center Cloud operations. Its geographical segments include the United States and Canada, of which it generates the majority of revenue from the United States.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: